{"title": "Targeted treatment shrinks deadly pediatric brain tumors", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/personalized_medicine.xml", "value": "Targeted treatment shrinks deadly pediatric brain tumors"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/01/190123082214.htm"}], "link": "https://www.sciencedaily.com/releases/2019/01/190123082214.htm", "summary": "For children -- whose tiny bodies are still growing -- chemotherapy and radiation treatments can cause lifelong damage. Now, scientists have reported that a targeted therapy that blocks a protein called LSD1 was able to shrink tumors in mice with a form of pediatric brain cancer known as medulloblastoma. LSD1 inhibitors are currently under evaluation in clinical trials for other cancers.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/personalized_medicine.xml", "value": "For children -- whose tiny bodies are still growing -- chemotherapy and radiation treatments can cause lifelong damage. Now, scientists have reported that a targeted therapy that blocks a protein called LSD1 was able to shrink tumors in mice with a form of pediatric brain cancer known as medulloblastoma. LSD1 inhibitors are currently under evaluation in clinical trials for other cancers."}, "published": "Wed, 23 Jan 2019 08:22:14 EST", "published_parsed": [2019, 1, 23, 13, 22, 14, 2, 23, 0], "id": "https://www.sciencedaily.com/releases/2019/01/190123082214.htm", "guidislink": false}